2014 was a good year for developments in automated insulin delivery systems for patients with diabetes mellitus. Clinical trials shifted from research units to the outpatient setting, included both adult and adolescent individuals and were conducted over periods from overnight to 24 h, with improvements seen in time spent in the target glycaemic range and reduced risk of hypoglycaemia.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Bakhtiani, P. A., Zhao, L. M., El Youssef, J., Castle, J. R. & Ward, W. K. A review of artificial pancreas technologies with an emphasis on bi-hormonal therapy. Diabetes Obes. Metab. 15, 1065–1070 (2013).
Kovatchev, B. P. et al. Safety of outpatient closed-loop control: first randomized crossover trials of a wearable artificial pancreas. Diabetes Care 37, 1789–1796 (2014).
Ly, T. T. et al. Overnight glucose control with an automated, unified safety system in children and adolescents with type 1 diabetes at diabetes camp. Diabetes Care 37, 2310–2316 (2014).
Thabit, H. et al. Home use of closed-loop insulin delivery for overnight glucose control in adults with type 1 diabetes: a 4-week, multicentre, randomised crossover study. Lancet Diabetes Endocrinol. 2, 701–709 (2014).
Nimri, R. et al. MD-Logic overnight control for 6 weeks of home use in patients with type 1 diabetes: randomized crossover trial. Diabetes Care 37, 3025–3032 (2014).
Russell, S. J. et al. Outpatient glycemic control with a bionic pancreas in type 1 diabetes. N. Engl. J. Med. 371, 313–325 (2014).
Weinzimer, S. A. et al. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care 31, 934–939 (2008).
Luijf, Y. M. et al. Day and night closed-loop control in adults with type 1 diabetes: a comparison of two closed-loop algorithms driving continuous subcutaneous insulin infusion versus patient self-management. Diabetes Care 36, 3882–3887 (2013).
El-Khatib, F. H. et al. Autonomous and continuous adaptation of a bihormonal bionic pancreas in adults and adolescents with type 1 diabetes. J. Clin. Endocrinol. Metab. 99, 1701–1711 (2014).
Frier, B. M. Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications. Nat. Rev. Endocrinol. 10, 711–722 (2014).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
J.S.S. is a Director of Dexcom and owns shares in Dexcom and Tandem Diabetes Care.
Rights and permissions
About this article
Cite this article
Skyler, J. Progress towards a bionic pancreas. Nat Rev Endocrinol 11, 75–76 (2015). https://doi.org/10.1038/nrendo.2014.228
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrendo.2014.228
This article is cited by
-
A smart insulin patch
Nature (2015)